So if MPL gets to market like Relyvrio did, we can expect income of US$381m in its first 12 months, and peak sales of US $2.6b! With less than 500m SOI, that's a valuation of AUD $1.15 to AUD$7.84, WITHOUT even considering any PE multiples.
Pharmaust - Media & News, page-94
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.005(2.56%) |
Mkt cap ! $92.46M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.0¢ | $46.22K | 241.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 106726 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 146686 | 7 |
View Market Depth
| Last trade - 12.30pm 04/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |